CCL Products (India) Limited (CCL)

Fast Moving Consumer Goods · Agricultural Food & other Products · NSE · Updated 20 June 2026
₹1,137.3 ↑ 44.65% (1Y)

🎯 Key Takeaways

  • CCL Products (India) Limited is transitioning from a mature FMCG player into a growth-oriented enterprise with strategic emphasis on premiumization, direct-to-consumer (D2C) channels, and international expansion, particularly in the UK. The company is leveraging strong volume growth and operational efficiency to drive profitability, supported by a healthy balance sheet and disciplined capital allocation.
  • Revenue grew 2.7% QoQ to ₹758 in Q3FY25.
  • ⚠️ 1) Margin pressure from strategic investments in capacity expansion and international markets could temper EBITDA growth if returns are delayed. 2) Hi
Market Cap
₹14,906
P/E Ratio
54.3
Div Yield
0.00%
Promoter
0.0%

📖 The Story

CCL Products (India) Limited is transitioning from a mature FMCG player into a growth-oriented enterprise with strategic emphasis on premiumization, direct-to-consumer (D2C) channels, and international expansion, particularly in the UK. The company is leveraging strong volume growth and operational efficiency to drive profitability, supported by a healthy balance sheet and disciplined capital allocation. Management is targeting 15% volume and EBITDA growth in FY27, signaling confidence in sustained momentum despite a high valuation multiple.

📰 What's Happening

In Q4 FY26, CCL reported robust financial performance with revenue of ₹1,226.39 crores (+46% YoY) and net profit of ₹114.53 crores (+12% YoY), underpinned by 18-20% volume growth and improved margins. The company reduced net debt to ₹1,073 crores and highlighted D2C as a key growth driver, now contributing 20-25% of sales. Management emphasized strategic capacity expansion, premium brand development, and international markets as pillars of future growth, with no planned capex for two years but openness to strategic acquisitions or partnerships.

Source: Stock Announcements

📊 Quarterly Results (₹ Cr)

MetricQ4FY23Q1FY24Q2FY24Q3FY24Q4FY24Q1FY25Q2FY25Q3FY25
Revenue520655608664727773738758
Operating Profit115107111112122132138127
OPM %21.7%16.2%18.1%16.7%16.3%16.9%18.6%16.4%
Net Profit8561616365717463
EPS₹6.41₹4.56₹4.57₹4.76₹4.90₹5.37₹5.55₹4.73

Revenue has grown consistently over the past four quarters, rising from ₹520 crores in Q4 FY23 to ₹1,226 crores in Q4 FY26, reflecting strong demand and market penetration. While operating margins have stabilized around 16-18%, they remain resilient despite macro pressures, supported by volume gains and cost discipline. Net profit growth has outpaced revenue growth in recent quarters, indicating operating leverage, though margin expansion has plateaued in the most recent periods, suggesting incremental investments may be absorbing efficiency gains.

🔮 Management Outlook & What's Next

Management reaffirmed its guidance for 15% volume and EBITDA growth in FY27, citing a healthy balance sheet with net debt reduced to ₹1,073 crores and debt-to-equity at 0.5. They indicated that cash flow will be prioritized for debt reduction or shareholder returns, with no immediate capex plans but potential for strategic acquisitions or capacity partnerships. The focus remains on scaling premium brands, expanding D2C reach, and deepening international presence, particularly in the UK, as part of a longer-term structural growth narrative.

Extracted from official company announcements. Not StockFin.ai's opinion.

⚖️ Peer Comparison — Agricultural Food & other Products

Company MCap (₹ Cr) P/E ROCE ROE D/E
TATA CONSUMER PRODUCTS LIMITED 1.22 L Cr 83.2 9.4% 7.3% 0.09
Marico Limited 1.09 L Cr 67.8
Patanjali Foods Limited 50,036 30.3
AWL Agri Business Limited 25,958 21.8
CCL Products (India) Limited 14,906 54.3
LT Foods Limited 14,215 23.9
Balrampur Chini Mills Limited 10,897 26.5
Triveni Engineering & Industries Limited 8,190 38.6
KRBL Limited 7,756 17.8
Gujarat Ambuja Exports Limited 7,467 24.2

🔗 Peer Stock Analyses

TATACONSUMMARICOPATANJALIAWLLTFOODS

⚠️ Risk Factors

1) Margin pressure from strategic investments in capacity expansion and international markets could temper EBITDA growth if returns are delayed. 2) High valuation (P/E of 54.3) leaves limited room for execution misses, especially if volume growth slows in premium or international segments. 3) Dependence on D2C and UK markets introduces execution and geopolitical risks, particularly amid evolving trade dynamics post-Brexit.

📋 Recent Filings

🧠 Analyst's Read

CCL is executing a clear growth pivot with strong top-line momentum and improving profitability, but the premiumization and international expansion strategies carry execution risks that could impact margins and growth trajectories. Investors should monitor quarterly volume trends in D2C and international markets, as well as management’s ability to convert strategic investments into sustainable EBITDA growth, as key near-term catalysts.

Based on filing content and financial data. Not a recommendation.

Data sourced from stock announcements. Analysis generated by StockFin.ai.
For informational purposes only — not investment advice. Updated 2026-06-20.